OA10323A - Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins its preparation and use - Google Patents

Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins its preparation and use Download PDF

Info

Publication number
OA10323A
OA10323A OA60738A OA60738A OA10323A OA 10323 A OA10323 A OA 10323A OA 60738 A OA60738 A OA 60738A OA 60738 A OA60738 A OA 60738A OA 10323 A OA10323 A OA 10323A
Authority
OA
OAPI
Prior art keywords
taxol
cyclodextrin
taxotere
inclusion complex
taxus
Prior art date
Application number
OA60738A
Other languages
English (en)
Inventor
Lajos Szente
Jozsef Szejtli
Andrasne Vikmon
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of OA10323A publication Critical patent/OA10323A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Epoxy Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
OA60738A 1993-05-12 1995-11-10 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins its preparation and use OA10323A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9301373A HU213200B (en) 1993-05-12 1993-05-12 The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production

Publications (1)

Publication Number Publication Date
OA10323A true OA10323A (en) 1997-10-07

Family

ID=10983581

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60738A OA10323A (en) 1993-05-12 1995-11-10 Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins its preparation and use

Country Status (23)

Country Link
US (1) US6284746B1 (fr)
EP (1) EP0698018B1 (fr)
JP (1) JP3693341B2 (fr)
CN (1) CN1123030A (fr)
AT (1) ATE225340T1 (fr)
AU (1) AU693101B2 (fr)
BG (1) BG100207A (fr)
BR (1) BR9406292A (fr)
CA (1) CA2162716C (fr)
CZ (1) CZ291495A3 (fr)
DE (1) DE69431476T2 (fr)
DK (1) DK0698018T3 (fr)
ES (1) ES2184764T3 (fr)
FI (1) FI955424A0 (fr)
HU (1) HU213200B (fr)
IL (1) IL109613A (fr)
NO (1) NO954545D0 (fr)
OA (1) OA10323A (fr)
PL (1) PL311561A1 (fr)
PT (1) PT698018E (fr)
SK (1) SK140595A3 (fr)
WO (1) WO1994026728A1 (fr)
YU (1) YU26894A (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994341A (en) * 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
HUT73844A (en) * 1994-11-11 1996-09-30 Chinoin Gyogyszer Es Vegyeszet New taxol complexes and pharmaceutical compositions containing them
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
BR9907647B1 (pt) * 1998-02-05 2014-04-01 Novartis Ag Novartis S A Novartis Inc Formulação farmacêutica na forma de um concentrado para infusão, o qual deve ser diluído antes da administração, e solução para infusão
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
TWI321054B (en) * 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
GB0127677D0 (en) * 2001-11-19 2002-01-09 Vianex S A Inclusion complex
US20040106199A1 (en) * 2002-12-02 2004-06-03 Eliseev Alexey V. Charged cyclodextrin derivatives and their use in plant cell and tissue culture growth media
CN100486645C (zh) 2006-09-12 2009-05-13 南京师范大学 含有环糊精紫杉醇包合物的药物组合物及其制备方法
CN100411688C (zh) * 2006-09-12 2008-08-20 南京师范大学 含有环糊精/多烯紫杉醇包合物的药物组合物及其制备方法
CN101278929B (zh) * 2007-04-02 2011-05-18 王效山 含有藤黄酸类化合物的药物及藤黄酸类化合物的包合物的制备方法
ES2310122B1 (es) * 2007-04-20 2009-10-30 Instituto Cientifico Y Tecnologico De Navarra, S.A Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
ITMI20071321A1 (it) * 2007-07-04 2009-01-05 Sea Marconi Technologies Di Va Nanospugne a base di ciclodestrine come veicolo per farmaci antitumorali
CL2007003876A1 (es) * 2007-12-28 2008-03-07 Univ De Concepcion Y Lab Andro Complejo de inclusion que esta formado por disulfiram y ciclodextrina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de la dependencia de alcohol y cocaina.
PL2331092T3 (pl) 2008-08-21 2014-08-29 Univ Johns Hopkins Sposoby i kompozycje do podawania 3-halopirogronianiu i związków pochodnych w leczeniu nowotworu
CN106659683A (zh) * 2014-01-14 2017-05-10 约翰斯·霍普金斯大学 包封修饰的环糊精复合物的脂质体组合物及其应用
CN103920163B (zh) * 2014-03-14 2016-09-14 南京大学 一种紫杉醇复合物、制备方法及其应用
WO2017079563A1 (fr) 2015-11-06 2017-05-11 The Johns Hopkins University Procédés de traitement de la fibrose hépatique par l'administration de 3-bromopyruvate
GB201715008D0 (en) * 2017-09-18 2017-11-01 Inst De Medicina Molecular Faculdade De Medicina Univ De Lisboa TRPV2 Antagonists
CN110755371B (zh) 2018-07-25 2021-08-31 比卡生物科技（广州）有限公司 一种注射用多西他赛组合物及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU181703B (en) * 1980-05-09 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
JPS62120324A (ja) * 1985-11-20 1987-06-01 Nippon Junyaku Kk 有機物質の水溶化方法
JP2651567B2 (ja) * 1986-03-20 1997-09-10 花王株式会社 メチル化β−シクロデキストリン
IE62095B1 (en) * 1988-03-29 1994-12-14 Univ Florida Pharmaceutical formulations for parenteral use
JP2929108B2 (ja) * 1988-10-28 1999-08-03 株式会社資生堂 化粧料および粉末化粧料
IT1227626B (it) 1988-11-28 1991-04-23 Vectorpharma Int Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione
JPH02200671A (ja) * 1989-01-30 1990-08-08 Agency Of Ind Science & Technol インドールを抽出分離する方法およびインドール包接分離用薬剤
JPH035438A (ja) * 1989-05-31 1991-01-11 Kaken Pharmaceut Co Ltd フルルビプロフェン包接化合物およびこの包接化合物を用いる消炎鎮痛剤
GB8920135D0 (en) * 1989-09-06 1989-10-18 Erba Carlo Spa Use of dehydrated cyclodextrins for improving drug dissolution
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
HU212730B (en) 1990-03-28 1996-10-28 Chinoin Gyogyszer Es Vegyeszet Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them
DE69127256T2 (de) * 1990-05-21 1998-02-12 Toppan Printing Co Ltd Cyclodextrinderivat
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
US5278324A (en) * 1990-08-28 1994-01-11 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
JPH0753396A (ja) 1993-08-19 1995-02-28 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法および用途
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor

Also Published As

Publication number Publication date
JPH08510232A (ja) 1996-10-29
CA2162716A1 (fr) 1994-11-24
AU693101B2 (en) 1998-06-25
HU9301373D0 (en) 1993-09-28
YU26894A (sh) 1997-05-28
HUT68589A (en) 1995-06-28
PT698018E (pt) 2003-02-28
IL109613A0 (en) 1994-08-26
SK140595A3 (en) 1996-10-02
WO1994026728A1 (fr) 1994-11-24
ES2184764T3 (es) 2003-04-16
EP0698018A1 (fr) 1996-02-28
DE69431476T2 (de) 2003-06-18
JP3693341B2 (ja) 2005-09-07
CA2162716C (fr) 2005-03-08
CZ291495A3 (en) 1996-04-17
AU7008194A (en) 1994-12-12
IL109613A (en) 1997-09-30
EP0698018B1 (fr) 2002-10-02
CN1123030A (zh) 1996-05-22
HU213200B (en) 1997-03-28
DE69431476D1 (de) 2002-11-07
PL311561A1 (en) 1996-02-19
FI955424A (fi) 1995-11-10
DK0698018T3 (da) 2003-02-10
FI955424A0 (fi) 1995-11-10
NO954545L (no) 1995-11-10
BR9406292A (pt) 1995-12-26
US6284746B1 (en) 2001-09-04
ATE225340T1 (de) 2002-10-15
NO954545D0 (no) 1995-11-10
BG100207A (bg) 1996-05-31

Similar Documents

Publication Publication Date Title
OA10323A (en) Inclusion complexes of taxol or taxotere or taxus extract formed with cyclodextrins its preparation and use
CN101745119B (zh) 羧酸类药物-多糖偶联物及其制备方法与应用
JP2852421B2 (ja) 燐脂質類に対し、そして少くとも一種類の燐脂質に対して親和性を有する活性物質から成る微結晶、並びにその製造方法及びこの微結晶を含有する薬剤組成物
JP5103476B2 (ja) シクロデキストリン・ドセタキセルの包接体を含む薬物組成物及びその製造方法
CN102114246B (zh) 生物体病灶部位特异性释药的两亲性多糖衍生物载体及其药学组合物的制备和应用
Duchêne et al. Pharmaceutical and medical applications of cyclodextrins
AU5503001A (en) Amphiphilic macrocyclic derivatives and their analogues
JP2010502654A (ja) シクロデキストリン・パクリタクセルの包接体を含有する薬物組成物及びその製造方法
Khan et al. Cyclodextrin: an overview
EP2219678A2 (fr) Nanoparticules d'actifs therapeutiques de faible solubilite aqueuse
AU716704B2 (en) Novel complexes and their compositions
Mendez-Ardoy et al. Monodisperse nanoparticles from self-assembling amphiphilic cyclodextrins: modulable tools for the encapsulation and controlled release of pharmaceuticals
CN113201135B (zh) 一种活性氧响应性材料pam-sh的制备方法与应用
Pourkarim et al. Solubilization methods for paclitaxel and docetaxel: An overview
EP0886654A1 (fr) Thioureido-cyclodextrines, utilisables en particulier pour solubiliser des agents antitumoraux et antiparasitaires et leurs procedes de preparation
NZ267705A (en) Inclusion complexes of taxoid compounds with cyclodextrins
JP2010531827A (ja) 抗腫瘍剤用ビヒクルとしてのシクロデキストリン系ナノスポンジ
EP1232188B1 (fr) Cyclodextrines substituees par des groupements fluoroalkyles, leur preparation et leur utilisation
US6864246B2 (en) Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae
CN115960116A (zh) 偶联前药、纳米粒、药物组合物及制备方法和应用
CN117645637A (zh) 一种半乳糖胺-多西他赛偶联物及其制备方法和应用